Skip to main content

1 Result(s)

within Andreas Seeber Remove this filter Life Sciences Remove this filter

and

  1. No Access

    Article

    Tissue-specific thresholds of mutation burden associated with anti-PD-1/L1 therapy benefit and prognosis in microsatellite-stable cancers

    Immune checkpoint inhibitors (ICIs) targeting programmed cell death protein 1 or its ligand (PD-1/L1) have expanded the treatment landscape against cancers but are effective in only a subset of patients. Tumor...

    Maishara Muquith, Magdalena Espinoza, Andrew Elliott, Joanne **u… in Nature Cancer (2024)